Chinese researchers have identified a new therapeutic target for Parkinson's disease, a neurodegenerative disorder with high disability and mortality rates, and have successfully discovered a ...

Kazia Therapeutics (KZIA) announced a research grant awarded from The Michael J. Fox Foundation for Parkinson’s Research, MJFF, to fund ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Parkinson’s disease may be linked to a cholesterol by-product that helps harmful protein clumps spread in the brain, a ...

Chinese scientists say preventing cholesterol from being converted to 24-OHC might be an effective treatment for Parkinson's ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling ...

Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, problems/symptoms, and functioning.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...